DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC. et al.
Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
Clin Cancer Res Off J Am Assoc Cancer Res 2013;
19: 1858-72
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.